123I-N-(2-diethylaminoethyl)-2-iodobenzamide: a potential imaging agent for cutaneous melanoma staging.
Moins N, D'Incan M, Bonafous J, Bacin F, Labarre P, Moreau MF, Mestas D, Noirault E, Chossat F, Berthommier E, Papon J, Bayle M, Souteyrand P, Madelmont JC, Veyre A.
Moins N, et al. Among authors: mestas d.
Eur J Nucl Med Mol Imaging. 2002 Nov;29(11):1478-84. doi: 10.1007/s00259-002-0971-6. Epub 2002 Sep 11.
Eur J Nucl Med Mol Imaging. 2002.
PMID: 12397467
Clinical Trial.